RETROSPECTIVE HEALTHCARE CLAIMS DATA ANALYSIS FOR CHILDREN/ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER RECEIVING SECOND-LINE PHARMACOTHERAPY IN GERMANY, EVALUATING PATIENT CHARACTERISTICS AND HEALTHCARE COSTS

Farahbakhshian S, Flechsig S, Meise D, Borchert K, Greiner W, Braun S (2018)
In: VALUE IN HEALTH., 21(Suppl. 3). New york: Elsevier Science Inc: S279.

Kurzbeitrag Konferenz / Poster | Veröffentlicht| Englisch
 
Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Autor/in
Farahbakhshian, S.; Flechsig, S.; Meise, D.; Borchert, K.; Greiner, WolfgangUniBi; Braun, S.
Erscheinungsjahr
2018
Titel des Konferenzbandes
VALUE IN HEALTH
Band
21
Ausgabe
Suppl. 3
Seite(n)
S279
ISSN
1098-3015
eISSN
1524-4733
Page URI
https://pub.uni-bielefeld.de/record/2934388

Zitieren

Farahbakhshian S, Flechsig S, Meise D, Borchert K, Greiner W, Braun S. RETROSPECTIVE HEALTHCARE CLAIMS DATA ANALYSIS FOR CHILDREN/ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER RECEIVING SECOND-LINE PHARMACOTHERAPY IN GERMANY, EVALUATING PATIENT CHARACTERISTICS AND HEALTHCARE COSTS. In: VALUE IN HEALTH. Vol 21. New york: Elsevier Science Inc; 2018: S279.
Farahbakhshian, S., Flechsig, S., Meise, D., Borchert, K., Greiner, W., & Braun, S. (2018). RETROSPECTIVE HEALTHCARE CLAIMS DATA ANALYSIS FOR CHILDREN/ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER RECEIVING SECOND-LINE PHARMACOTHERAPY IN GERMANY, EVALUATING PATIENT CHARACTERISTICS AND HEALTHCARE COSTS. VALUE IN HEALTH, 21, S279. New york: Elsevier Science Inc. doi:10.1016/j.jval.2018.09.1663
Farahbakhshian, S., Flechsig, S., Meise, D., Borchert, K., Greiner, W., and Braun, S. (2018). “RETROSPECTIVE HEALTHCARE CLAIMS DATA ANALYSIS FOR CHILDREN/ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER RECEIVING SECOND-LINE PHARMACOTHERAPY IN GERMANY, EVALUATING PATIENT CHARACTERISTICS AND HEALTHCARE COSTS” in VALUE IN HEALTH, vol. 21, (New york: Elsevier Science Inc), S279.
Farahbakhshian, S., et al., 2018. RETROSPECTIVE HEALTHCARE CLAIMS DATA ANALYSIS FOR CHILDREN/ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER RECEIVING SECOND-LINE PHARMACOTHERAPY IN GERMANY, EVALUATING PATIENT CHARACTERISTICS AND HEALTHCARE COSTS. In VALUE IN HEALTH. no.21 New york: Elsevier Science Inc, pp. S279.
S. Farahbakhshian, et al., “RETROSPECTIVE HEALTHCARE CLAIMS DATA ANALYSIS FOR CHILDREN/ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER RECEIVING SECOND-LINE PHARMACOTHERAPY IN GERMANY, EVALUATING PATIENT CHARACTERISTICS AND HEALTHCARE COSTS”, VALUE IN HEALTH, vol. 21, New york: Elsevier Science Inc, 2018, pp.S279.
Farahbakhshian, S., Flechsig, S., Meise, D., Borchert, K., Greiner, W., Braun, S.: RETROSPECTIVE HEALTHCARE CLAIMS DATA ANALYSIS FOR CHILDREN/ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER RECEIVING SECOND-LINE PHARMACOTHERAPY IN GERMANY, EVALUATING PATIENT CHARACTERISTICS AND HEALTHCARE COSTS. VALUE IN HEALTH. 21, p. S279. Elsevier Science Inc, New york (2018).
Farahbakhshian, S., Flechsig, S., Meise, D., Borchert, K., Greiner, Wolfgang, and Braun, S. “RETROSPECTIVE HEALTHCARE CLAIMS DATA ANALYSIS FOR CHILDREN/ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER RECEIVING SECOND-LINE PHARMACOTHERAPY IN GERMANY, EVALUATING PATIENT CHARACTERISTICS AND HEALTHCARE COSTS”. VALUE IN HEALTH. New york: Elsevier Science Inc, 2018.Vol. 21. S279.